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A 25-year-old man presented to our hospital with an 
eight-day history of high-grade fever, associated with 
generalized body ache and vomiting. For the past two 
days, he also complained of blurry vision and 
headache. Past medical history was unremarkable. 
Physical examination revealed a blood pressure of 
104/66 mmHg, a pulse of 104 per minute and a 
temperature of 102oF. He was awake with intact higher 
mental functions. Cranial nerves were intact. He had a 
painless maculopapular rash over his left arm. The neck 
was supple. His fundus showed bilateral papilledema. 
Motor examination revealed a mild right upper limb 
weakness with the Medical Research Council (MRC) 
grading of 4/5. Motor strength was normal in remaining 
limbs. Deep tendon reflexes were normal. Sensory and 
cerebellar examination was unremarkable. 
Laboratory investigations revealed thrombocytopenia 
with a platelet count of 77,000/cmm, a white cell 
count of 13,000/cmm with 88.9% neutrophils, and a 
hemoglobin of 12 g/dL. Liver enzymes were elevated 
with aspartate aminotransferase (AST) of 59 IU/L 
(Normal <35 IU/L) and alanine aminotransferase (ALT) 
of 222 IU/L (Normal <45 IU/L). Further testing revealed 
positive IgM antibodies against the dengue virus. 
Malarial parasite was not detected. We did not test for 
chikungunya virus or other arboviruses. Cranial 
magnetic resonance imaging (MRI) with venogram was 
performed (Figure 1), which revealed filling defects in 
the right transverse sinus, right sigmoid sinus, straight 
sinus and superior sagittal sinus representing cerebral 
venous sinus thrombosis. Electroencephalography 
(EEG) showed diffuse slowing suggestive of 
encephalopathy. No epileptiform discharges were seen. 
An extensive laboratory evaluation for hypercoagulable 
states was negative.
Figure 1: Magnetic Resonance Imaging (MRI) of brain 
showing hemorrhagic infarct in the right parietal lobe 
(yellow arrow in panel A). Magnetic resonance 
venogram showing non-visualization of right transverse 
sinus (yellow arrow in panel B).
He was diagnosed with cerebral venous sinus 
thrombosis (CVST) secondary to dengue infection. He 
was managed with intravenous hydration, 
acetaminophen, and anticoagulation with 
subcutaneous enoxaparin 1 mg per kg every 12-hourly, 
which was later switched to rivaroxaban 20 mg once 
daily. Platelet counts were monitored twice a day. On 
the 2nd day of admission, he had one episode of 
generalized-onset tonic-clonic seizure. There was no 
past history or family history of seizures. He was started 
on levetiracetam 500 mg twice daily. On the 4th day of 
hospital admission, his blurring vision and headache 
improved. His right arm weakness recovered 
completely at the time of discharge. 
DISCUSSION:
Dengue viral fever is an acute febrile illness presenting 
with fever, headache, joint and muscle pain, and 
decreased platelets (thrombocytopenia). It is caused by 
a dengue virus (DENV), which is an arbovirus belonging 
to the Flaviviridae family. DENV is transmitted by the 
bites of female Aedes mosquitoes, Aedes  aegypti and 
Aedes albopictus. DENV has four serotypes (DENV-1 
through DENV-4) [1]. Dengue fever is currently a 
pandemic condition. According to the statistics by the 
World Health Organization (WHO), approximately 400 
million dengue viral infections occur annually. This 
number is still under-reported as a large number of 
cases are asymptomatic, mildly symptomatic and 
self-managed, or misdiagnosed as other febrile 
illnesses [2]. The WHO reported more than 47,000 
cases of dengue fever in Pakistan in four months from 
July to November 2019, with 75 confirmed deaths [3].
Neurological manifestations associated with dengue 
viral fever are uncommon but well-known and occur in 
about 1% of total cases [4]. The neurological 
manifestations include meningoencephalitis, 
Guillain-Barre syndrome (GBS), acute disseminated 
encephalomyelitis (ADEM), transverse myelitis, stroke, 
and cranial nerve pathologies, with 
meningoencephalitis being the most common 
neurological manifestation[5,6]. Although 
thrombocytopenia is one of the cardinal features of 
dengue fever and increases the risk of bleeding, the 
cases of large vessel thrombosis have been reported [7]. 
A number of factors have been suggested with dengue 
fever that increase the risk of thrombosis. Dengue virus 
enhances thrombomodulin expression by activating 
endothelial cells. Activated protein C is downregulated 
due to thrombomodulin-thrombin-protein C complex 
formation. Low antithrombin III and protein C and S 
levels were previously found in severe dengue but in our 
case, no similar risk factors were seen [8]. Cerebral 
venous sinus thrombosis (CVST) is one of the rare 
thrombotic complications associated with dengue fever 
and previously only two case reports have been 
reported in the literature [9,10]. This is the first case from 
Pakistan.
Anticoagulation is the main treatment strategy for 
CVST, even in hemorrhagic CVST [11]. The decision to 
anticoagulate in patients with CVST and positive 
dengue serology is challenging due to accompanying 
thrombocytopenia. Vasanthi et al. [9] managed their 
patient with parenteral fluids replacement only and did 
not institute anticoagulation therapy. However, Tilara et 
al. [10] administered anticoagulation with subcutaneous 
low molecular weight heparin in their case. We initially 
managed our patient with therapeutic subcutaneous 
enoxaparin followed by oral rivaroxaban, along with 
parenteral hydration. We monitored platelet counts 
twice daily. Our plan was to continue anticoagulation for 
at least three months and transfuse platelets if the 
platelet count decreased below 50,000/cmm or the 
patient had symptomatic bleeding but none of these 
complications occurred. In all the cases of dengue 
virus-associated CVST, including our case, the patients 
achieved complete neurological recovery.
CONCLUSION:
Cerebral venous sinus thrombosis is rarely associated 
with dengue fever. Anticoagulation and parenteral fluid 
replacement are the main treatment regimens for 
patients with CVST. The serial platelet counts and the 
risk of bleeding should be assessed when treating with 
anticoagulation in these patients. The prognosis is 
excellent with complete recovery in all three cases 
reported to date.
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ABSTRACT:
Dengue fever is a viral febrile illness caused by dengue virus and spread by Aedes mosquito worldwide. It usually 
manifests as an acute fever associated with body ache, skin rash, and thrombocytopenia. Neurological manifestations 
are relatively uncommon but well-known. We report a case of a 25-year-old male patient who presented to our hospital 
with acute febrile illness, headache, and vomiting. Extensive laboratory investigations were done and he was diagnosed 
with cerebral venous sinus thrombosis. Dengue serology was positive. He was treated with anticoagulation and 
hydration with complete recovery. The treatment with anticoagulation is challenging due to accompanying 
thrombocytopenia. Only two previous case reports of cerebral venous sinus thrombosis with positive dengue serology 
have been reported in the literature.  
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A 25-year-old man presented to our hospital with an 
eight-day history of high-grade fever, associated with 
generalized body ache and vomiting. For the past two 
days, he also complained of blurry vision and 
headache. Past medical history was unremarkable. 
Physical examination revealed a blood pressure of 
104/66 mmHg, a pulse of 104 per minute and a 
temperature of 102oF. He was awake with intact higher 
mental functions. Cranial nerves were intact. He had a 
painless maculopapular rash over his left arm. The neck 
was supple. His fundus showed bilateral papilledema. 
Motor examination revealed a mild right upper limb 
weakness with the Medical Research Council (MRC) 
grading of 4/5. Motor strength was normal in remaining 
limbs. Deep tendon reflexes were normal. Sensory and 
cerebellar examination was unremarkable. 
Laboratory investigations revealed thrombocytopenia 
with a platelet count of 77,000/cmm, a white cell 
count of 13,000/cmm with 88.9% neutrophils, and a 
hemoglobin of 12 g/dL. Liver enzymes were elevated 
with aspartate aminotransferase (AST) of 59 IU/L 
(Normal <35 IU/L) and alanine aminotransferase (ALT) 
of 222 IU/L (Normal <45 IU/L). Further testing revealed 
positive IgM antibodies against the dengue virus. 
Malarial parasite was not detected. We did not test for 
chikungunya virus or other arboviruses. Cranial 
magnetic resonance imaging (MRI) with venogram was 
performed (Figure 1), which revealed filling defects in 
the right transverse sinus, right sigmoid sinus, straight 
sinus and superior sagittal sinus representing cerebral 
venous sinus thrombosis. Electroencephalography 
(EEG) showed diffuse slowing suggestive of 
encephalopathy. No epileptiform discharges were seen. 
An extensive laboratory evaluation for hypercoagulable 
states was negative.
Figure 1: Magnetic Resonance Imaging (MRI) of brain 
showing hemorrhagic infarct in the right parietal lobe 
(yellow arrow in panel A). Magnetic resonance 
venogram showing non-visualization of right transverse 
sinus (yellow arrow in panel B).
He was diagnosed with cerebral venous sinus 
thrombosis (CVST) secondary to dengue infection. He 
was managed with intravenous hydration, 
acetaminophen, and anticoagulation with 
subcutaneous enoxaparin 1 mg per kg every 12-hourly, 
which was later switched to rivaroxaban 20 mg once 
daily. Platelet counts were monitored twice a day. On 
the 2nd day of admission, he had one episode of 
generalized-onset tonic-clonic seizure. There was no 
past history or family history of seizures. He was started 
on levetiracetam 500 mg twice daily. On the 4th day of 
hospital admission, his blurring vision and headache 
improved. His right arm weakness recovered 
completely at the time of discharge. 
DISCUSSION:
Dengue viral fever is an acute febrile illness presenting 
with fever, headache, joint and muscle pain, and 
decreased platelets (thrombocytopenia). It is caused by 
a dengue virus (DENV), which is an arbovirus belonging 
to the Flaviviridae family. DENV is transmitted by the 
bites of female Aedes mosquitoes, Aedes  aegypti and 
Aedes albopictus. DENV has four serotypes (DENV-1 
through DENV-4) [1]. Dengue fever is currently a 
pandemic condition. According to the statistics by the 
World Health Organization (WHO), approximately 400 
million dengue viral infections occur annually. This 
number is still under-reported as a large number of 
cases are asymptomatic, mildly symptomatic and 
self-managed, or misdiagnosed as other febrile 
illnesses [2]. The WHO reported more than 47,000 
cases of dengue fever in Pakistan in four months from 
July to November 2019, with 75 confirmed deaths [3].
Neurological manifestations associated with dengue 
viral fever are uncommon but well-known and occur in 
about 1% of total cases [4]. The neurological 
manifestations include meningoencephalitis, 
Guillain-Barre syndrome (GBS), acute disseminated 
encephalomyelitis (ADEM), transverse myelitis, stroke, 
and cranial nerve pathologies, with 
meningoencephalitis being the most common 
neurological manifestation[5,6]. Although 
thrombocytopenia is one of the cardinal features of 
dengue fever and increases the risk of bleeding, the 
cases of large vessel thrombosis have been reported [7]. 
A number of factors have been suggested with dengue 
fever that increase the risk of thrombosis. Dengue virus 
enhances thrombomodulin expression by activating 
endothelial cells. Activated protein C is downregulated 
due to thrombomodulin-thrombin-protein C complex 
formation. Low antithrombin III and protein C and S 
levels were previously found in severe dengue but in our 
case, no similar risk factors were seen [8]. Cerebral 
venous sinus thrombosis (CVST) is one of the rare 
thrombotic complications associated with dengue fever 
and previously only two case reports have been 
reported in the literature [9,10]. This is the first case from 
Pakistan.
Anticoagulation is the main treatment strategy for 
CVST, even in hemorrhagic CVST [11]. The decision to 
anticoagulate in patients with CVST and positive 
dengue serology is challenging due to accompanying 
thrombocytopenia. Vasanthi et al. [9] managed their 
patient with parenteral fluids replacement only and did 
not institute anticoagulation therapy. However, Tilara et 
al. [10] administered anticoagulation with subcutaneous 
low molecular weight heparin in their case. We initially 
managed our patient with therapeutic subcutaneous 
enoxaparin followed by oral rivaroxaban, along with 
parenteral hydration. We monitored platelet counts 
twice daily. Our plan was to continue anticoagulation for 
at least three months and transfuse platelets if the 
platelet count decreased below 50,000/cmm or the 
patient had symptomatic bleeding but none of these 
complications occurred. In all the cases of dengue 
virus-associated CVST, including our case, the patients 
achieved complete neurological recovery.
CONCLUSION:
Cerebral venous sinus thrombosis is rarely associated 
with dengue fever. Anticoagulation and parenteral fluid 
replacement are the main treatment regimens for 
patients with CVST. The serial platelet counts and the 
risk of bleeding should be assessed when treating with 
anticoagulation in these patients. The prognosis is 
excellent with complete recovery in all three cases 
reported to date.
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A 25-year-old man presented to our hospital with an 
eight-day history of high-grade fever, associated with 
generalized body ache and vomiting. For the past two 
days, he also complained of blurry vision and 
headache. Past medical history was unremarkable. 
Physical examination revealed a blood pressure of 
104/66 mmHg, a pulse of 104 per minute and a 
temperature of 102oF. He was awake with intact higher 
mental functions. Cranial nerves were intact. He had a 
painless maculopapular rash over his left arm. The neck 
was supple. His fundus showed bilateral papilledema. 
Motor examination revealed a mild right upper limb 
weakness with the Medical Research Council (MRC) 
grading of 4/5. Motor strength was normal in remaining 
limbs. Deep tendon reflexes were normal. Sensory and 
cerebellar examination was unremarkable. 
Laboratory investigations revealed thrombocytopenia 
with a platelet count of 77,000/cmm, a white cell 
count of 13,000/cmm with 88.9% neutrophils, and a 
hemoglobin of 12 g/dL. Liver enzymes were elevated 
with aspartate aminotransferase (AST) of 59 IU/L 
(Normal <35 IU/L) and alanine aminotransferase (ALT) 
of 222 IU/L (Normal <45 IU/L). Further testing revealed 
positive IgM antibodies against the dengue virus. 
Malarial parasite was not detected. We did not test for 
chikungunya virus or other arboviruses. Cranial 
magnetic resonance imaging (MRI) with venogram was 
performed (Figure 1), which revealed filling defects in 
the right transverse sinus, right sigmoid sinus, straight 
sinus and superior sagittal sinus representing cerebral 
venous sinus thrombosis. Electroencephalography 
(EEG) showed diffuse slowing suggestive of 
encephalopathy. No epileptiform discharges were seen. 
An extensive laboratory evaluation for hypercoagulable 
states was negative.
Figure 1: Magnetic Resonance Imaging (MRI) of brain 
showing hemorrhagic infarct in the right parietal lobe 
(yellow arrow in panel A). Magnetic resonance 
venogram showing non-visualization of right transverse 
sinus (yellow arrow in panel B).
He was diagnosed with cerebral venous sinus 
thrombosis (CVST) secondary to dengue infection. He 
was managed with intravenous hydration, 
acetaminophen, and anticoagulation with 
subcutaneous enoxaparin 1 mg per kg every 12-hourly, 
which was later switched to rivaroxaban 20 mg once 
daily. Platelet counts were monitored twice a day. On 
the 2nd day of admission, he had one episode of 
generalized-onset tonic-clonic seizure. There was no 
past history or family history of seizures. He was started 
on levetiracetam 500 mg twice daily. On the 4th day of 
hospital admission, his blurring vision and headache 
improved. His right arm weakness recovered 
completely at the time of discharge. 
DISCUSSION:
Dengue viral fever is an acute febrile illness presenting 
with fever, headache, joint and muscle pain, and 
decreased platelets (thrombocytopenia). It is caused by 
a dengue virus (DENV), which is an arbovirus belonging 
to the Flaviviridae family. DENV is transmitted by the 
bites of female Aedes mosquitoes, Aedes  aegypti and 
Aedes albopictus. DENV has four serotypes (DENV-1 
through DENV-4) [1]. Dengue fever is currently a 
pandemic condition. According to the statistics by the 
World Health Organization (WHO), approximately 400 
million dengue viral infections occur annually. This 
number is still under-reported as a large number of 
cases are asymptomatic, mildly symptomatic and 
self-managed, or misdiagnosed as other febrile 
illnesses [2]. The WHO reported more than 47,000 
cases of dengue fever in Pakistan in four months from 
July to November 2019, with 75 confirmed deaths [3].
Neurological manifestations associated with dengue 
viral fever are uncommon but well-known and occur in 
about 1% of total cases [4]. The neurological 
manifestations include meningoencephalitis, 
Guillain-Barre syndrome (GBS), acute disseminated 
encephalomyelitis (ADEM), transverse myelitis, stroke, 
and cranial nerve pathologies, with 
meningoencephalitis being the most common 
neurological manifestation[5,6]. Although 
thrombocytopenia is one of the cardinal features of 
dengue fever and increases the risk of bleeding, the 
cases of large vessel thrombosis have been reported [7]. 
A number of factors have been suggested with dengue 
fever that increase the risk of thrombosis. Dengue virus 
enhances thrombomodulin expression by activating 
endothelial cells. Activated protein C is downregulated 
due to thrombomodulin-thrombin-protein C complex 
formation. Low antithrombin III and protein C and S 
levels were previously found in severe dengue but in our 
case, no similar risk factors were seen [8]. Cerebral 
venous sinus thrombosis (CVST) is one of the rare 
thrombotic complications associated with dengue fever 
and previously only two case reports have been 
reported in the literature [9,10]. This is the first case from 
Pakistan.
Anticoagulation is the main treatment strategy for 
CVST, even in hemorrhagic CVST [11]. The decision to 
anticoagulate in patients with CVST and positive 
dengue serology is challenging due to accompanying 
thrombocytopenia. Vasanthi et al. [9] managed their 
patient with parenteral fluids replacement only and did 
not institute anticoagulation therapy. However, Tilara et 
al. [10] administered anticoagulation with subcutaneous 
low molecular weight heparin in their case. We initially 
managed our patient with therapeutic subcutaneous 
enoxaparin followed by oral rivaroxaban, along with 
parenteral hydration. We monitored platelet counts 
twice daily. Our plan was to continue anticoagulation for 
at least three months and transfuse platelets if the 
platelet count decreased below 50,000/cmm or the 
patient had symptomatic bleeding but none of these 
complications occurred. In all the cases of dengue 
virus-associated CVST, including our case, the patients 
achieved complete neurological recovery.
CONCLUSION:
Cerebral venous sinus thrombosis is rarely associated 
with dengue fever. Anticoagulation and parenteral fluid 
replacement are the main treatment regimens for 
patients with CVST. The serial platelet counts and the 
risk of bleeding should be assessed when treating with 
anticoagulation in these patients. The prognosis is 
excellent with complete recovery in all three cases 
reported to date.
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